Key points
- In the CDC's 2023 survey, adults aged 50 to 64 made up 10.6% and adults 65 and older 4.9% of all US adults with a current ADHD diagnosis.
- A meta-analysis of adults 50 and older found that 2.18% met ADHD criteria on research scales while only 0.23% had a clinical diagnosis and 0.09% were being treated.
- The criteria require several symptoms before age 12, which is the main feature separating ADHD from cognitive decline that begins in later life.
- An Israeli cohort study found a higher rate of dementia among adults with an ADHD diagnosis; this is an association and does not show that ADHD causes dementia.
- FDA labels for common ADHD medications state that the drugs have not been studied, or not adequately studied, in people 65 and older.
People over 50 come to the question of ADHD from two directions. Some recognize a lifelong pattern, often after a child or grandchild is diagnosed or after retirement removes the structure that kept things working. Others notice new lapses in memory and focus and want to know what is happening. The two situations are handled very differently.
How common ADHD is after 50
The CDC's 2023 national survey found that adults aged 50 to 64 accounted for 10.6% of all US adults with a current ADHD diagnosis, and adults 65 and older for 4.9%.
Research suggests many more go unrecognized. A meta-analysis of 20 studies in adults aged 50 and older found that 2.18% met criteria for ADHD on validated research scales. Only 0.23% had a clinical diagnosis, and 0.09% were receiving treatment. The distance between those three numbers is the finding: most older adults who screen as having ADHD in research have never been diagnosed.
That fits what the National Institute of Mental Health says about late diagnosis in general: parents and teachers may not have recognized the disorder, and girls were especially likely to be missed. A general account of late recognition is in can you develop ADHD as an adult?
How ADHD is told apart from cognitive decline
The deciding question is timing. The diagnostic criteria require that several ADHD symptoms were present before age 12. ADHD is a lifelong pattern. Cognitive decline is a change from how a person used to function.
| Question | Points toward ADHD | Points toward something new |
|---|---|---|
| When did it start? | Traceable to childhood and present through adult life | Began in the last months or few years |
| Is it changing? | Broadly stable, varying with demands and stress | Getting steadily worse |
| What do people who have known you for decades say? | "You have always been like this" | "This is not like you" |
| What was school and early work like? | Similar difficulties, even if you coped | No comparable difficulties |
The table shows how the timing rule is applied. It cannot sort any individual. Symptoms overlap, and the two can coexist. The National Institute of Mental Health notes that inattentive symptoms often persist with age while hyperactivity and impulsivity tend to decline, so ADHD in a 65-year-old can look mostly like forgetfulness and disorganization.
Other common causes of poor concentration in later life also need to be checked. The CDC lists sleep disorders, anxiety and depression among conditions that can produce symptoms similar to ADHD, and CHADD notes that an adult evaluation includes a medical exam to rule out causes such as thyroid problems.
New or worsening memory, confusion or trouble with familiar tasks should be assessed by a physician. Under the diagnostic criteria, attention problems that first appear in later life are not ADHD.
ADHD and dementia: what one large study found
A study published in JAMA Network Open in 2023 followed 109,218 Israeli adults aged 51 to 70 for 17 years. Dementia developed in 13.2% of those with an adult ADHD diagnosis and 7.0% of those without, an adjusted hazard ratio of 2.77.
Several limits apply. Only 730 participants, 0.7% of the cohort, had an adult ADHD diagnosis. The data come from one health system. An association of this kind does not show that ADHD causes dementia, and it says nothing about any one person's future. It is a reason for researchers to keep looking and for clinicians to take new cognitive symptoms seriously in a patient with ADHD instead of attributing everything to the existing diagnosis.
Getting evaluated later in life
An evaluation after 50 follows the same standard as at any age: a detailed history from childhood forward, evidence of impairment in more than one setting, rating scales and screening for other conditions. Two features differ in practice.
- Childhood evidence is harder to find. Parents may have died and school records may be gone. Siblings, a long-term spouse, old friends and your own account of early school years can fill the gap. See getting evaluated without childhood records.
- The medical picture is fuller. A list of every medication and supplement, recent blood pressure readings, and the results of any memory or neurological testing all help the evaluator.
The practice's evaluation page explains how an evaluation is structured.
Treatment cautions in older adults
The evidence base thins with age, and it is worth knowing where.
- Labels. The FDA label for one long-acting mixed amphetamine product states that it has not been studied in the geriatric population, and the label for immediate-release methylphenidate says the same. The label for the non-stimulant atomoxetine says its clinical studies did not include enough patients 65 and older to determine whether they respond differently. Two extended-release methylphenidate products carry adult indications that stop at age 65.
- Blood pressure and heart. Stimulant labels direct prescribers to monitor blood pressure and pulse and to avoid use in patients with serious cardiac disease. The atomoxetine label calls for a careful cardiovascular history and exam before treatment.
- Long-term data. The large Swedish study that linked longer medication use with higher odds of hypertension and arterial disease covered people aged 6 to 64. It included no one older.
- Other medications. Older adults tend to take more of them, and a prescriber needs the full list to check for interactions.
A lack of studies in older adults means uncertainty, and it does not mean treatment is ruled out. The decision is individual and is made with the prescriber, often in coordination with a primary care doctor or cardiologist. For the cardiovascular evidence in detail, see ADHD medication, heart health and blood pressure.
Medicare in brief
Most New Yorkers 65 and older have Medicare. The essentials as of October 2026:
- Visits. Medicare Part B covers outpatient mental health care, including psychiatric evaluation and medication management. After the Part B deductible, the patient pays 20% of the Medicare-approved amount.
- Prescriptions. Part D plans set their own formularies and rules. In 2026 the Part D out-of-pocket cap is $2,100, after which covered drugs cost nothing for the rest of the year. Check a specific plan's formulary for the medication in question.
- Telehealth. Through December 31, 2027, Medicare beneficiaries can receive telehealth services anywhere in the United States. A requirement for periodic in-person visits for mental health telehealth is scheduled to apply after that date unless Congress changes it. That is a Medicare payment rule and is separate from the federal rules on prescribing controlled substances by telehealth.
Whether a particular psychiatrist bills Medicare is a question for that practice. For this one, see fees and insurance. The comparison article Medicare and adult ADHD: visits, prescriptions and telehealth covers costs, Medicare Advantage and the telehealth rules in full, and is the next page to read.
Questions
Can you be diagnosed with ADHD at 60 or 70?
Yes. There is no upper age limit for diagnosis. The evaluation must establish that several symptoms were present before age 12 and that symptoms cause impairment now.
Is it ADHD or early dementia?
The main distinction is timing. ADHD is a pattern that goes back to childhood, while dementia is a decline from an earlier level of functioning. Only a clinical assessment can sort this out, and new memory problems should be evaluated by a physician.
Does ADHD get worse with age?
NIMH notes that symptoms may change with age: inattention often persists while hyperactivity and impulsivity are more likely to decline. Changes in routine, such as retirement or caregiving, can also make long-standing symptoms more noticeable.
Are stimulants safe for people over 65?
FDA labels for common ADHD medications state that they have not been studied, or not adequately studied, in people 65 and older, so the evidence is limited. Prescribers weigh heart health, blood pressure and other medications case by case and monitor blood pressure and pulse during treatment.
Does Medicare cover an ADHD evaluation?
Medicare Part B covers outpatient mental health care, including psychiatric evaluation and medication management, with the patient paying 20% of the Medicare-approved amount after the Part B deductible. Coverage applies when the clinician bills Medicare, so confirm that with the practice first.
Sources
- CDC MMWR: ADHD Diagnosis, Treatment, and Telehealth Use in Adults, United States, October-November 2023 (October 10, 2024)
- Dobrosavljevic et al., Neuroscience and Biobehavioral Reviews: Prevalence of ADHD in older adults, systematic review and meta-analysis (November 2020)
- Levine et al., JAMA Network Open: Adult ADHD and the risk of dementia (October 17, 2023)
- National Institute of Mental Health: ADHD in Adults, What You Need to Know (2024)
- CDC: Diagnosing ADHD (reviewed July 30, 2026)
- DailyMed: Adderall XR prescribing information, section 8.5 Geriatric Use (label effective April 30, 2026)
- DailyMed: Ritalin prescribing information (label effective February 5, 2025)
- DailyMed: Strattera prescribing information (label effective June 30, 2026)
- Zhang et al., JAMA Psychiatry: ADHD medications and long-term risk of cardiovascular diseases (February 2024)
- Medicare.gov: Mental health care (outpatient) (accessed October 13, 2026)
- Medicare.gov: Costs for Medicare drug coverage, 2026 (accessed October 13, 2026)
- CMS: Telehealth FAQ (updated October 8, 2026)
- DailyMed: Concerta prescribing information, indication and section 8.5 (label effective April 20, 2026)
